SK

Sivasubramanian Karunalaya Pandian

Active Director Director DIN 08262914
DIN 08262914 First appointment Oct 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sivasubramanian Karunalaya Pandian

Data last updated:

Sivasubramanian Karunalaya Pandian is a Director at Sunera Meditech Private Limited (since 2018). The company operates in Healthcare.

DIN 08262914
Primary Designation Director
Industry Healthcare
First Appointment 23 Oct 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sunera Meditech Private Limited U33119TN2018PTC125373
Director23 Oct 20182018Active

Board colleagues of Sivasubramanian Karunalaya Pandian

NameDINCompanyDesignation
Radha08262915Sunera Meditech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sunera Meditech Private Limited
Premium access

Shareholding and investment profile for Sivasubramanian Karunalaya Pandian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivasubramanian Karunalaya Pandian

Sivasubramanian Karunalaya Pandian currently holds 1 directorship: Sunera Meditech Private Limited (Director, since 23 Oct 2018).

Sivasubramanian Karunalaya Pandian was first appointed on 23 Oct 2018 as Director at Sunera Meditech Private Limited.

The current boards of Sivasubramanian Karunalaya Pandian's companies include Radha (Sunera Meditech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available